Day 1
December 13 2016
9:00—17:00
Registration (King Abdullah International Medical Research Center Main Lobby)
20:00— 21:30
Official Opening Ceremony
Day 2
December 14 2016
7:00— 8:00
Registration
8:00—10:00
Session 1: Contributing to the Saudi National Vision 2030: Strengthening Medical Biotechnology Development.
Session Chairman: Dr. Abdelali Haoudi, Head Strategy & Business Development, KAIMRC
8:00—8:15
Innovation in Medical R&D: a cornerstone in knowledge based economy
8:15–8:30
RVC/ Pioneering Venture Capital Investment in KSA
8:30–8:45
RPDC role in bridging the gap between laboratory research and commercial production (Transforming Innovation into Impact)
8:45–9:00
Fostering and Supporting Innovation & Technology Development Through Intellectual Property Rights
9:00 – 9:15
Contributing to the National Vision 2030 by Leveraging Population Resources for Public Health and Economic Growth
9:15—9:30
Using Public/private partnerships to incentivize innovation in management of diseases of significant societal impact.
9:30–10:00
Panel Discussion
10:00–10:30
Break
10:30—12:00
Session 2: Strategic R&D Focus Area - Cancer.
10:30–10:45
biomarker driven cancer therapy
10:45–11:00
Integrated omics for cancer therapy
11:00–11:15
Anti-Cancer Drug Development: Potentiation using natural products
11:15–11:30
New Horizons in Cancer: Induction of Cellular Immunity for the Prevention of Relapse
11:30–12:00
Panel Discussion
12:00—14:00
Lunch Break + Posters Session
14:00—15:40
Session 3: Strategic R&D Focus Area - Diabetes.
14:00–14:15
Diabetes in Saudi Arabia: Burden on health and Economy
14:15–14:30
Weight management of type 2 diabetes: Pharmacotherapeutic alternatives to bariatric surgery
14:30–14:45
Genomic Medicine from basic research to precision medicine: a project for Saudi Arabia
14:45–15:00
Gene Expression Changes After Bariatric Surgery: a prospective analysis
15:00–15:45
Panel Discussion
15:45–16:45
Break + Posters
16:45—18:15
Session 4: Strategic R&D Focus Area - Infectious Diseases.
16:45–17:00
MERS-CoV: Current knowledge and gaps
17:00–17:15
NIAID Advances in MERS and Coronavirus Research
17:15–17:30
Simian adenovirus vectored vaccines for emerging pathogens
17:45–18:15
Panel Discussion
Day 3
December 15 2016
8:00—10:30
Session 5: Strategic R&D Focus Area - Cardiovascular Diseases.
8:00–8:15
Enhancing Physical Activity, a Target for Vision 2030
8:15–8:30
Clinical Strategies for Heart Regeneration
8:30–8:45
CHD genetics : Complex but Promising field in Saudi Population
8:45–9:00
Panel Discussion
10:00–11:00
Break + Posters Session
11:00—12:30
Session 6: Measuring the Impact of Research.
11:00–11:15
Presentation 1
11:15–11:30
Presentation 2
11:30–11:45
Accessing Basic Human Biology and its Impact on Health Care and Industry
11:45–12:45
Panel Discussion
12:45—14:00
Lunch Break + Posters Session
14:00–14:15
Conducting and reporting health research that editors will want to publish
14:30—14:45
Towards Highly Cited Publications: KACST Role
14:45–15:00
Characteristics of high standards publication: A quantitative approach
15:00–15:30
Panel Discussion
15:30—16:00
Break
16:00—18:00
Session 8: Improving Health through science: Phase 1 Clinical Trials.
16:00–16:15
Medical Research from Drug Regulatory Authority Prospective
16:15–16:30
Experience with randomized controlled trials in Saudi Arabia
16:30–16:45
rapid clinical development for emerging pathogen vaccines
16:45–17:00
Improved trial designs for greater safety, higher efficacy and better value
17:00—17:30
Panel Discussion
17:30—18:00
Research Award Ceremony